Laura M. Amendola

Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium

Laura M. Amendola, Gail P. Jarvik, Michael C. Leo et al. · The American Journal of Human Genetics · 2016 · 564 citations · Full text

Sequencing, Medicine, Genetics +14

ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG)

David T. Miller, Kristy Lee, Wendy K. Chung et al. · Genetics in Medicine · 2021 · 541 citations · Full text

Secondary Findings, Acmg Sf, Next-generation Sequencing +9

Actionable, Pathogenic Incidental Findings in 1,000 Participants’ Exomes

Michael O. Dorschner, Laura M. Amendola, Emily H. Turner et al. · The American Journal of Human Genetics · 2013 · 381 citations · Full text

Pathogenic Incidental Findings, Genetic Epidemiology, Mendelian Disorder +1

Return of Genomic Results to Research Participants: The Floor, the Ceiling, and the Choices In Between

Gail P. Jarvik, Laura M. Amendola, Jonathan S. Berg et al. · The American Journal of Human Genetics · 2014 · 368 citations · Full text

Genomic Results, Genetic Testing, Research Participants +9

ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG)

David T. Miller, Kristy Lee, Noura S. Abul‐Husn et al. · Genetics in Medicine · 2023 · 364 citations · Full text

Secondary Findings, Sequencing, Acmg Sf +7